These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129 [TBL] [Abstract][Full Text] [Related]
24. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Yates CM; Simpson J; Gordon A Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479 [TBL] [Abstract][Full Text] [Related]
25. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218 [TBL] [Abstract][Full Text] [Related]
26. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia. Arai H; Moroji T; Kosaka K Neurosci Lett; 1984 Nov; 52(1-2):73-8. PubMed ID: 6152043 [TBL] [Abstract][Full Text] [Related]
27. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341 [TBL] [Abstract][Full Text] [Related]
28. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Henke H; Lang W Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677 [TBL] [Abstract][Full Text] [Related]
29. Brain muscarinic receptors in senile dementia. Rinne JO; Laakso K; Lönnberg P; Mölsä P; Paljärvi L; Rinne JK; Säkö E; Rinne UK Brain Res; 1985 Jun; 336(1):19-25. PubMed ID: 4005573 [TBL] [Abstract][Full Text] [Related]
30. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. Shimohama S; Taniguchi T; Fujiwara M; Kameyama M J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287 [TBL] [Abstract][Full Text] [Related]
31. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia. Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747 [TBL] [Abstract][Full Text] [Related]
32. The ageing brain and dementia--a review. Davison AN Br J Clin Pract Suppl; 1985 Jun; 39():3-6. PubMed ID: 2864054 [No Abstract] [Full Text] [Related]
33. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187 [TBL] [Abstract][Full Text] [Related]
35. An update on the neurochemistry of Alzheimer disease. Davies P Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134 [No Abstract] [Full Text] [Related]
36. CCK receptors and human neurological disease. Hays SE; Paul SM Life Sci; 1982 Jul; 31(4):319-22. PubMed ID: 6292647 [TBL] [Abstract][Full Text] [Related]